Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,884,403 papers from all fields of science
Search
Sign In
Create Free Account
Opana
Known as:
Endo brand of oxymorphine HCl
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
1 ML Oxymorphone Hydrochloride 1 MG/ML Injection [Opana]
12 HR Oxymorphone Hydrochloride 10 MG Extended Release Oral Tablet [Opana]
Broader (2)
Oxymorphone
Oxymorphone Hydrochloride
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Opana-induced thrombotic microangiopathy masquerading as thrombotic thrombocytopenic purpura
B. H. Ban
,
A. Verma
,
M. Tudor
,
J. Sethi
Oxford Medical Case Reports
2017
Corpus ID: 11590371
Abstract Opana (oxymorphone) is a powerful semi-synthetic opioid agonist used for chronic pain management that is ingested orally…
Expand
2017
2017
Oxymorphone Induced Thrombotic Microangiopathy Mimicking Atypical Haemolytic Uremic Syndrome.
A. Gandhi
,
S. Ullah
,
Shani Kotadia
,
S. Nasser
Journal of Ayub Medical College
2017
Corpus ID: 39571761
BACKGROUND Atypical Haemolytic Uremic Syndrome (aHUS) is a rare life threatening entity characterized by thrombocytopenia…
Expand
2017
2017
A mechanistic investigation of thrombotic microangiopathy associated with IV abuse of Opana ER.
R. Hunt
,
Ayla Yalamanoglu
,
+9 authors
C. Kimchi-Sarfaty
Blood
2017
Corpus ID: 43580941
Since 2012, a number of case reports have described the occurrence of thrombotic microangiopathy (TMA) following IV abuse of…
Expand
Review
2017
Review
2017
Untangling the web of opioid addictions in the USA
T. Lancet
The Lancet
2017
Corpus ID: 195669604
Review
2016
Review
2016
Primary care providers' prescribing practices of opioid controlled substances.
L. Shields
,
Soraya Nasraty
,
+4 authors
J. Honaker
Journal of Opioid Management
2016
Corpus ID: 2595550
OBJECTIVE Prescription opioid abuse poses a significant public health concern. House Bill 1 (HB1) was enacted in 2012 to address…
Expand
2014
2014
Changes in prescriptions of OxyContin and Opana after introduction of tamper resistant formulations among potentially problematic and comparator prescribers
H. Chilcoat
,
R. Abrams
,
S. Natarajan
,
P. Coplan
2014
Corpus ID: 71712822
2014
2014
Chronic pain, addiction, and Zohydro.
Y. Olsen
,
J. Sharfstein
New England Journal of Medicine
2014
Corpus ID: 205110432
Twenty-nine state attorneys general have asked the FDA to reconsider its approval of the opioid Zohydro, which lacks abuse…
Expand
2013
2013
FDA denies request to block generic versions of Opana ER
T. Walker
2013
Corpus ID: 73923900
FDA has denied Endo Health Solutions' petition to block generic forms of its opioid agonist Opana ER, which contains oxymorphone…
Expand
2013
2013
Opana-ER used the wrong way: intravenous abuse leading to microangiopathic hemolysis and a TTP-like syndrome.
A. I. Amjad
,
Rahul A Parikh
Blood
2013
Corpus ID: 35923364
![Figure][1] A 23-year-old white woman with a history of intravenous drug abuse presented to the emergency department with…
Expand
2009
2009
Concentration of oxymorphone in postmortem fluids and tissue.
D. Garside
,
R. L. Hargrove
,
Ruth E. Winecker
Journal of Analytical Toxicology
2009
Corpus ID: 8684917
Oxymorphone, a semi-synthetic opioid analgesic, has been available as Numorphan since the 1950s in the form of injectable…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE